INBX - Inhibrx Biosciences Inc.
73.5
1.870 2.544%
Share volume: 122,565
Last Updated: 03-11-2026
Pharmaceutical Products/Biological Products, Except Diagnostic Substances:
-0.04%
PREVIOUS CLOSE
CHG
CHG%
$71.63
1.87
0.03%
Summary score
41%
Profitability
50%
Dept financing
34%
Liquidity
58%
Performance
30%
Sector
Manufacturing
Industry
Pharmaceutical Products/Biological Products, Except Diagnostic Substances
Long-term ratios 30-Sep-2021 - 30-Sep-2025
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
-42.95%
Return on assets
37.9%
Return on sales
-70199.24%
Return on invested capital
233.33%
Total debt ratio
74.36%
Debt ratio change over timeo
-0.64%
Current Ratio
6.34%
Quick Ratio
7.15%
Cash Position Ratio
6.04%
Short-term ratios 30-Sep-2024 - 30-Sep-2025
The data are presented for the financials results of the quarters of the last year.
Return on equity
0%
Return on assets
-18.39%
Return on sales
0%
Return on invested capital
0%
Total debt ratio
55.48%
Debt ratio change over timeo
0%
Current Ratio
4.51%
Quick Ratio
0%
Cash Position Ratio
4.32%
Last quarter ratios 30-Sep-2025
The data are presented for the financials results of the last quarter.
Return on equity
0%
Return on assets
-19.08%
Return on sales
0%
Return on invested capital
0%
Total debt ratio
79.25%
Debt ratio change over time
0%
Current Ratio
4.49%
Quick Ratio
0%
Cash Position Ratio
4.25%
Performance ratios (change over 4 years) 30-Sep-2021 - 30-Sep-2025
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
-132.49%
Return on assets
-48.42%
Return on sales
-40224.73%
Return on invested capital
-9.68%
Total debt ratio
-63.96%
Debt ratio change over time
-0.64%
Current Ratio
2.13%
Quick Ratio
1.95%
Cash Position Ratio
1.97%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
| Long-term ratios | INBX | AMGN | GILD | BIIB |
|---|---|---|---|---|
| Return on equity | -42.95% | 28.34% | 5.51% | 6.15% |
| Return on assets | 37.9% | 3.06% | 3.18% | 2.21% |
| Return on sales | -70199.24% | 28.09% | 27.06% | 23.01% |
| Return on invested capital | 233.33% | 6.42% | 3.22% | 6.7% |
| Profitability | 50% | 53% | 31% | 28% |
| Total debt ratio | 74.36% | 93.19% | 66.22% | 44.66% |
| Debt ratio change over time | -0.64% | 12.76% | 169.64% | 13.01% |
| Dept financing | 20% | 27% | 43% | 14% |
| Current Ratio | 4.51% | 1.25% | 1.43% | 2% |
| Quick Ratio | 0% | 0.95% | 1.29% | 1.44% |
| Cash Position Ratio | 4.32% | 0.43% | 0.63% | 0.74% |
| Liquididy | 75% | 15% | 12% | 17% |
| Short-term ratios | INBX | AMGN | GILD | BIIB |
|---|---|---|---|---|
| Return on equity | 0% | 0% | 0% | 0% |
| Return on assets | -18.39% | 3.09% | 4.74% | 1.98% |
| Return on sales | 0% | 23.81% | 35.93% | 22.2% |
| Return on invested capital | 0% | 0% | 0% | 0% |
| Profitability | 50% | 33% | 50% | 26% |
| Total debt ratio | 55.48% | 91.88% | 65.29% | 38.81% |
| Debt ratio change over time | 0% | 0% | 0% | 0% |
| Dept financing | 40% | 25% | 18% | 11% |
| Current Ratio | 4.51% | 1.25% | 1.43% | 2% |
| Quick Ratio | 0% | 0.95% | 1.29% | 1.44% |
| Cash Position Ratio | 4.32% | 0.43% | 0.63% | 0.74% |
| Liquididy | 50% | 26% | 34% | 40% |